Form 8-K - Current report:
SEC Accession No. 0001477932-25-004754
Filing Date
2025-06-23
Accepted
2025-06-23 15:00:20
Documents
16
Period of Report
2025-06-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bglc_8k.htm   iXBRL 8-K 28449
2 THE SERVICE CONTRACT bglc_ex107.htm EX-10.7 56994
8 bglc_ex101img2.jpg GRAPHIC 2197
  Complete submission text file 0001477932-25-004754.txt   220313

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bglc-20250617.xsd EX-101.SCH 5874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bglc-20250617_lab.xml EX-101.LAB 15195
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bglc-20250617_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bglc-20250617_pre.xml EX-101.PRE 9631
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bglc-20250617_def.xml EX-101.DEF 2099
19 EXTRACTED XBRL INSTANCE DOCUMENT bglc_8k_htm.xml XML 4042
Mailing Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200
Business Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200 1-307-241-6898
BioNexus Gene Lab Corp (Filer) CIK: 0001737523 (see all company filings)

EIN.: 262124961 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41750 | Film No.: 251064631
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)